Research and innovation in robotics in the clinical trial operations sector has declined in the last year.
The most recent figures show that the number of robotics related patent applications in the industry stood at 34 in the three months ending February – down from 64 over the same period in 2021.
Figures for patent grants related to robotics followed a similar pattern to filings – shrinking from 48 in the three months ending February 2021 to 29 in the same period in 2022.
The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.
Robotics is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.
The figures also provide an insight into the largest innovators in the sector.
Johnson & Johnson was the top robotics innovator in the clinical trial operations sector in the latest quarter. The company, which has its headquarters in the United States, filed 17 robotics related patents in the three months ending February. That was down from 35 over the same period in 2021.
It was followed by the Switzerland based F. Hoffmann-La Roche Ltd with seven robotics patent applications, the United States based Thermo Fisher Scientific Inc (6 applications), and Japan based Takeda Pharmaceutical Co Ltd (2 applications).